Navigation Links
Insmed Announces European Medicines Agency Acceptance of Its Pediatric Investigation Plan for ARIKACE™ in the Cystic Fibrosis Pseudomonas Indication
Date:3/3/2011

ion, please visit http://www.insmed.com.

Forward-Looking Statements This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to the results of clinical trials, the development of our products, or the business strategies, plans and objectives of management, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements.  The risks and uncertainties include, without limitation, we may be unsuccessful in developing our product candidates, our expenses may be higher than anticipated and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K for the year ended December 31, 2009 and Quarterly Report on Form 10-Q for the fiscal quarters ended March 31, 2010, June 30, 2010 and September 30, 2010.  Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release.  We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events. Investor Relations Contact:Brian Ritchie - FD212-850-5683brian.ritchie@fd.com  Media Contact:Irma Gomez-Dib - FD212-850-5761Irma.gomez-dib@fd.com
'/>"/>

SOURCE Insmed Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective
2. Insmed Shareholders Approve Conversion of Series B Conditional Convertible Preferred Stock and Reverse Stock Split
3. Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call
4. NASDAQ Grants Insmed Incorporated 180-Day Extension to Regain Compliance with Minimum Bid Price Rule
5. Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2010
6. Insmed to Host Third Quarter 2010 Conference Call
7. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
8. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
9. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
10. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
11. Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  Mallinckrodt plc (NYSE: MNK ... approved a share repurchase program. The open-ended authorization permits ... Mallinckrodt plc ordinary shares. "Funding additional ... priorities as we continue to pursue a range of ...
(Date:1/23/2015)... January 23, 2015 Heptares Therapeutics, the clinical-stage ... announce that the Malcolm Campbell Memorial Prize for ... President of Chemistry), Fiona Marshall (Chief Scientific Officer ... and co-founder) for the seminal contributions to GPCR drug discovery ...
(Date:1/22/2015)... a privately held medical device company, announced today that ... ITOCHU Corporation (Tokyo Stock Exchange TYO: 8001) to sell ... cancer in Japan . ViewRay,s technology, ... only MRI-guided radiation therapy system that images and treats ...
Breaking Medicine Technology:Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
... The global cardiovascular device industry is expanding quickly, ... billion by 2015. The boom in ... the world,s growing number of heart health-related diseases: the ... in the world currently suffer from cardiovascular diseases. ...
... (Nasdaq: BIOD ) today announced that Dr. Errol ... at the 6th Annual JMP Securities Healthcare Conference at the ... for Tuesday, September 27, 2011 at 8:30 a.m. ET (5:30 ... replay of the presentation, please visit the Investors section of ...
Cached Medicine Technology:Cardiovascular Device Market Research Update- September 2011 2
(Date:1/22/2015)... Chemo Duck Program is pleased to announce the release of the ... with cancer. The Chemo Duck App, available on iTunes for use ... to help children of all ages living with cancer adjust to ... entertained, educated and at ease while waiting for clinic visits or ...
(Date:1/22/2015)... is a famous wedding dress company offering many trendy designs. ... Facebook, Twitter, and Pinterest. The fans will have an opportunity ... every week. , Moreover, the company has extended its 2015 ... homepage for more information. , Angelweddingdress is a ...
(Date:1/22/2015)... 2015 Juvent Sports ( http://www.juventsports.com ) ... PGA Merchandise Show to bestow a Juvent Sports Achievement ... golfer, Arlene McKitrick. The award commemorated and congratulated McKitrick ... win. She won her first amateur tournament in 1979 ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 For over 20 years, ... Oceanside and Vista area has treated just about every ... personal injury circumstances. And for those same twenty-plus years, the ... of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... 2015 Yesterday, Senator Holly Mitchell ... Kristin Olsen (R-Modesto) were honored by the California ... biotechnology, biomedical science, medical device and pharmaceutical innovation ... the “2014 Life Sciences Champion” award from CHI ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... State University School of Medicine post-doctoral researcher has secured ... triggers a type of breast cancer to transform into ... trainee in the Department of Pharmacology, has secured a ... Cancer Research Program for his study, "Paracrine Cytokine/Chemokine Pathways ...
... Dotinga HealthDay Reporter , FRIDAY, Dec. 23 (HealthDay ... good grasp on quantum theory, genetic engineering and the space-time ... how one jolly, bearded guy manages to get gifts to ... And never mind what you may have heard about his ...
... 22, 2011) Radiology researchers at The University of ... evidence that multiple sclerosis affects an area of the ... from the disabling damage caused by the disease,s visible ... as the benchmark for the study conducted by faculty ...
... (HealthDay News) -- Some toys at the top of children,s Christmas ... They measured the noise levels of 24 popular toys and bought ... toys exceeded 90 decibels and several reached 100 decibels or more, ... chain saw or subway train. Extended, unprotected exposure to sounds ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Dec. ... the world more people are suffering from acid reflux, likely ... a new study suggests. In Norway, the prevalence of ... almost 50 percent in the past 10 years, say researchers ...
... method of identifying medical test results and other ... which requires a common terminology to ensure that ... used when and where the patient needs it. ... the 2,000 most frequently reported laboratory test observations, ...
Cached Medicine News:Health News:Wayne State receives DOD grant; study may give insight to slow or halt breast cancer 2Health News:Scientists Ponder Santa's High-Tech Secrets 2Health News:UTHealth researchers link multiple sclerosis to different area of brain 2Health News:Noisy Toys Might Harm Kids' Hearing 2Health News:As Obesity Rises, More Suffer From Acid Reflux 2Health News:Lingua franca critical for electronic medical records and health information exchange 2
... monitoring for flexible care settings., ... combine portability and measurement flexibility to ... of intermediate care environmentsat the patients ... heritage in patient monitoring, IntelliVue has ...
... hospital-grade monitoring capabilities into the growing health ... state management. The system is unique ... range of clinical applications, from continuous real-time ... periodic monitoring of patients outside the hospital, ...
Generra Focus 5 is a basic vital sign monitor. , ,Adult, pediatric, and neonatal. , ,Providing high quality, affordable products for efficiency in patient care....
... The Acuity Central Monitoring Station ... for up to 60 patients from ... interface uses simple point and click ... trackball. The clinician can initiate or ...
Medicine Products: